aluates Reports

$ 0.0

Automative

Global Non-Invasive Cancer Detection Market Research Report 2026

Published Date: 2026-02-10

Report Code: QYRE-Auto-13O18478

Global Non Invasive Cancer Detection Market Research Report 2024

BUY CHAPTERS

Global Non-Invasive Cancer Detection Market Research Report 2026

Code: QYRE-Auto-13O18478

Report

2026-02-10

Pages:102

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Datar Cancer Genetics

Nucleix

miR Scientific

Owlstone Medical

bioAffinity Technologies

Nonacus, Inc.

AMADIX

Trublood

Non-Invasive Cancer Detection Market

The global Non-Invasive Cancer Detection market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

Non-invasive cancer testing is a technology that detects cancer by analyzing biomarkers in body fluids such as blood, urine, and saliva without surgery or tissue biopsy. Common non-invasive testing methods include liquid biopsy, genetic testing, and imaging technology, which can detect cancer-related DNA, RNA, proteins, or circulating tumor cells (CTCs) to detect cancer early or monitor disease progression. Non-invasive testing is more comfortable for patients and has lower risks, and is particularly suitable for cancer screening, treatment effect evaluation, and recurrence monitoring.

The North American market for Non-Invasive Cancer Detection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Non-Invasive Cancer Detection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Non-Invasive Cancer Detection in Prostate Cancer is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Non-Invasive Cancer Detection include Trublood, Datar Cancer Genetics, Nucleix, miR Scientific, Owlstone Medical, bioAffinity Technologies, Nonacus, Amadix, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Non-Invasive Cancer Detection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Non-Invasive Cancer Detection. The Non-Invasive Cancer Detection market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Non-Invasive Cancer Detection market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Non-Invasive Cancer Detection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Non-Invasive Cancer Detection Market Report

Report Metric	Details
Report Name	Non-Invasive Cancer Detection Market
Segment by Type	Imaging Test Nuclear Medicine Test Others
Segment by Application	Prostate Cancer Bladder Cancer Pancreatic Cancer Breast Cancer Gastric Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Trublood, Datar Cancer Genetics, Nucleix, miR Scientific, Owlstone Medical, bioAffinity Technologies, Nonacus, Amadix
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Non-Invasive Cancer Detection companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Non-Invasive Cancer Detection Market report?

Ans: The main players in the Non-Invasive Cancer Detection Market are Trublood, Datar Cancer Genetics, Nucleix, miR Scientific, Owlstone Medical, bioAffinity Technologies, Nonacus, Amadix

What are the Application segmentation covered in the Non-Invasive Cancer Detection Market report?

Ans: The Applications covered in the Non-Invasive Cancer Detection Market report are Prostate Cancer, Bladder Cancer, Pancreatic Cancer, Breast Cancer, Gastric Cancer, Others

What are the Type segmentation covered in the Non-Invasive Cancer Detection Market report?

Ans: The Types covered in the Non-Invasive Cancer Detection Market report are Imaging Test, Nuclear Medicine Test, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-Invasive Cancer Detection Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Imaging Test

1.2.3 Nuclear Medicine Test

1.2.4 Others

1.3 Market by Application

1.3.1 Global Non-Invasive Cancer Detection Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Prostate Cancer

1.3.3 Bladder Cancer

1.3.4 Pancreatic Cancer

1.3.5 Breast Cancer

1.3.6 Gastric Cancer

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non-Invasive Cancer Detection Market Perspective (2021–2032)

2.2 Global Non-Invasive Cancer Detection Growth Trends by Region

2.2.1 Global Non-Invasive Cancer Detection Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Non-Invasive Cancer Detection Historic Market Size by Region (2021–2026)

2.2.3 Non-Invasive Cancer Detection Forecasted Market Size by Region (2027–2032)

2.3 Non-Invasive Cancer Detection Market Dynamics

2.3.1 Non-Invasive Cancer Detection Industry Trends

2.3.2 Non-Invasive Cancer Detection Market Drivers

2.3.3 Non-Invasive Cancer Detection Market Challenges

2.3.4 Non-Invasive Cancer Detection Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Non-Invasive Cancer Detection Players by Revenue

3.1.1 Global Top Non-Invasive Cancer Detection Players by Revenue (2021–2026)

3.1.2 Global Non-Invasive Cancer Detection Revenue Market Share by Players (2021–2026)

3.2 Global Top Non-Invasive Cancer Detection Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Non-Invasive Cancer Detection Revenue

3.4 Global Non-Invasive Cancer Detection Market Concentration Ratio

3.4.1 Global Non-Invasive Cancer Detection Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-Invasive Cancer Detection Revenue in 2025

3.5 Global Key Players of Non-Invasive Cancer Detection Head Offices and Areas Served

3.6 Global Key Players of Non-Invasive Cancer Detection, Products and Applications

3.7 Global Key Players of Non-Invasive Cancer Detection, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Non-Invasive Cancer Detection Breakdown Data by Type

4.1 Global Non-Invasive Cancer Detection Historic Market Size by Type (2021–2026)

4.2 Global Non-Invasive Cancer Detection Forecasted Market Size by Type (2027–2032)

5 Non-Invasive Cancer Detection Breakdown Data by Application

5.1 Global Non-Invasive Cancer Detection Historic Market Size by Application (2021–2026)

5.2 Global Non-Invasive Cancer Detection Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Non-Invasive Cancer Detection Market Size (2021–2032)

6.2 North America Non-Invasive Cancer Detection Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Non-Invasive Cancer Detection Market Size by Country (2021–2026)

6.4 North America Non-Invasive Cancer Detection Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Non-Invasive Cancer Detection Market Size (2021–2032)

7.2 Europe Non-Invasive Cancer Detection Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Non-Invasive Cancer Detection Market Size by Country (2021–2026)

7.4 Europe Non-Invasive Cancer Detection Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Non-Invasive Cancer Detection Market Size (2021–2032)

8.2 Asia-Pacific Non-Invasive Cancer Detection Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Non-Invasive Cancer Detection Market Size by Region (2021–2026)

8.4 Asia-Pacific Non-Invasive Cancer Detection Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Non-Invasive Cancer Detection Market Size (2021–2032)

9.2 Latin America Non-Invasive Cancer Detection Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Non-Invasive Cancer Detection Market Size by Country (2021–2026)

9.4 Latin America Non-Invasive Cancer Detection Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Non-Invasive Cancer Detection Market Size (2021–2032)

10.2 Middle East & Africa Non-Invasive Cancer Detection Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Non-Invasive Cancer Detection Market Size by Country (2021–2026)

10.4 Middle East & Africa Non-Invasive Cancer Detection Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Trublood

11.1.1 Trublood Company Details

11.1.2 Trublood Business Overview

11.1.3 Trublood Non-Invasive Cancer Detection Introduction

11.1.4 Trublood Revenue in Non-Invasive Cancer Detection Business (2021–2026)

11.1.5 Trublood Recent Development

11.2 Datar Cancer Genetics

11.2.1 Datar Cancer Genetics Company Details

11.2.2 Datar Cancer Genetics Business Overview

11.2.3 Datar Cancer Genetics Non-Invasive Cancer Detection Introduction

11.2.4 Datar Cancer Genetics Revenue in Non-Invasive Cancer Detection Business (2021–2026)

11.2.5 Datar Cancer Genetics Recent Development

11.3 Nucleix

11.3.1 Nucleix Company Details

11.3.2 Nucleix Business Overview

11.3.3 Nucleix Non-Invasive Cancer Detection Introduction

11.3.4 Nucleix Revenue in Non-Invasive Cancer Detection Business (2021–2026)

11.3.5 Nucleix Recent Development

11.4 miR Scientific

11.4.1 miR Scientific Company Details

11.4.2 miR Scientific Business Overview

11.4.3 miR Scientific Non-Invasive Cancer Detection Introduction

11.4.4 miR Scientific Revenue in Non-Invasive Cancer Detection Business (2021–2026)

11.4.5 miR Scientific Recent Development

11.5 Owlstone Medical

11.5.1 Owlstone Medical Company Details

11.5.2 Owlstone Medical Business Overview

11.5.3 Owlstone Medical Non-Invasive Cancer Detection Introduction

11.5.4 Owlstone Medical Revenue in Non-Invasive Cancer Detection Business (2021–2026)

11.5.5 Owlstone Medical Recent Development

11.6 bioAffinity Technologies

11.6.1 bioAffinity Technologies Company Details

11.6.2 bioAffinity Technologies Business Overview

11.6.3 bioAffinity Technologies Non-Invasive Cancer Detection Introduction

11.6.4 bioAffinity Technologies Revenue in Non-Invasive Cancer Detection Business (2021–2026)

11.6.5 bioAffinity Technologies Recent Development

11.7 Nonacus

11.7.1 Nonacus Company Details

11.7.2 Nonacus Business Overview

11.7.3 Nonacus Non-Invasive Cancer Detection Introduction

11.7.4 Nonacus Revenue in Non-Invasive Cancer Detection Business (2021–2026)

11.7.5 Nonacus Recent Development

11.8 Amadix

11.8.1 Amadix Company Details

11.8.2 Amadix Business Overview

11.8.3 Amadix Non-Invasive Cancer Detection Introduction

11.8.4 Amadix Revenue in Non-Invasive Cancer Detection Business (2021–2026)

11.8.5 Amadix Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Datar Cancer Genetics

Nucleix

miR Scientific

Owlstone Medical

bioAffinity Technologies

Nonacus, Inc.

AMADIX

Trublood

List of Tables

Table 1. Global Non-Invasive Cancer Detection Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Imaging Test

Table 3. Key Players of Nuclear Medicine Test

Table 4. Key Players of Others

Table 5. Global Non-Invasive Cancer Detection Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Non-Invasive Cancer Detection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Non-Invasive Cancer Detection Market Size by Region (US$ Million), 2021–2026

Table 8. Global Non-Invasive Cancer Detection Market Share by Region (2021–2026)

Table 9. Global Non-Invasive Cancer Detection Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Non-Invasive Cancer Detection Market Share by Region (2027–2032)

Table 11. Non-Invasive Cancer Detection Market Trends

Table 12. Non-Invasive Cancer Detection Market Drivers

Table 13. Non-Invasive Cancer Detection Market Challenges

Table 14. Non-Invasive Cancer Detection Market Restraints

Table 15. Global Non-Invasive Cancer Detection Revenue by Players (US$ Million), 2021–2026

Table 16. Global Non-Invasive Cancer Detection Market Share by Players (2021–2026)

Table 17. Global Top Non-Invasive Cancer Detection Players by Tier (Tier 1, Tier 2, and Tier 3), based on Non-Invasive Cancer Detection Revenue, 2025

Table 18. Ranking of Global Top Non-Invasive Cancer Detection Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Non-Invasive Cancer Detection Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Non-Invasive Cancer Detection, Headquarters and Area Served

Table 21. Global Key Players of Non-Invasive Cancer Detection, Products and Applications

Table 22. Global Key Players of Non-Invasive Cancer Detection, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Non-Invasive Cancer Detection Market Size by Type (US$ Million), 2021–2026

Table 25. Global Non-Invasive Cancer Detection Revenue Market Share by Type (2021–2026)

Table 26. Global Non-Invasive Cancer Detection Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Non-Invasive Cancer Detection Revenue Market Share by Type (2027–2032)

Table 28. Global Non-Invasive Cancer Detection Market Size by Application (US$ Million), 2021–2026

Table 29. Global Non-Invasive Cancer Detection Revenue Market Share by Application (2021–2026)

Table 30. Global Non-Invasive Cancer Detection Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Non-Invasive Cancer Detection Revenue Market Share by Application (2027–2032)

Table 32. North America Non-Invasive Cancer Detection Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Non-Invasive Cancer Detection Market Size by Country (US$ Million), 2021–2026

Table 34. North America Non-Invasive Cancer Detection Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Non-Invasive Cancer Detection Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Non-Invasive Cancer Detection Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Non-Invasive Cancer Detection Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Non-Invasive Cancer Detection Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Non-Invasive Cancer Detection Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Non-Invasive Cancer Detection Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Non-Invasive Cancer Detection Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Non-Invasive Cancer Detection Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Non-Invasive Cancer Detection Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Non-Invasive Cancer Detection Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Non-Invasive Cancer Detection Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Non-Invasive Cancer Detection Market Size by Country (US$ Million), 2027–2032

Table 47. Trublood Company Details

Table 48. Trublood Business Overview

Table 49. Trublood Non-Invasive Cancer Detection Product

Table 50. Trublood Revenue in Non-Invasive Cancer Detection Business (US$ Million), 2021–2026

Table 51. Trublood Recent Development

Table 52. Datar Cancer Genetics Company Details

Table 53. Datar Cancer Genetics Business Overview

Table 54. Datar Cancer Genetics Non-Invasive Cancer Detection Product

Table 55. Datar Cancer Genetics Revenue in Non-Invasive Cancer Detection Business (US$ Million), 2021–2026

Table 56. Datar Cancer Genetics Recent Development

Table 57. Nucleix Company Details

Table 58. Nucleix Business Overview

Table 59. Nucleix Non-Invasive Cancer Detection Product

Table 60. Nucleix Revenue in Non-Invasive Cancer Detection Business (US$ Million), 2021–2026

Table 61. Nucleix Recent Development

Table 62. miR Scientific Company Details

Table 63. miR Scientific Business Overview

Table 64. miR Scientific Non-Invasive Cancer Detection Product

Table 65. miR Scientific Revenue in Non-Invasive Cancer Detection Business (US$ Million), 2021–2026

Table 66. miR Scientific Recent Development

Table 67. Owlstone Medical Company Details

Table 68. Owlstone Medical Business Overview

Table 69. Owlstone Medical Non-Invasive Cancer Detection Product

Table 70. Owlstone Medical Revenue in Non-Invasive Cancer Detection Business (US$ Million), 2021–2026

Table 71. Owlstone Medical Recent Development

Table 72. bioAffinity Technologies Company Details

Table 73. bioAffinity Technologies Business Overview

Table 74. bioAffinity Technologies Non-Invasive Cancer Detection Product

Table 75. bioAffinity Technologies Revenue in Non-Invasive Cancer Detection Business (US$ Million), 2021–2026

Table 76. bioAffinity Technologies Recent Development

Table 77. Nonacus Company Details

Table 78. Nonacus Business Overview

Table 79. Nonacus Non-Invasive Cancer Detection Product

Table 80. Nonacus Revenue in Non-Invasive Cancer Detection Business (US$ Million), 2021–2026

Table 81. Nonacus Recent Development

Table 82. Amadix Company Details

Table 83. Amadix Business Overview

Table 84. Amadix Non-Invasive Cancer Detection Product

Table 85. Amadix Revenue in Non-Invasive Cancer Detection Business (US$ Million), 2021–2026

Table 86. Amadix Recent Development

Table 87. Research Programs/Design for This Report

Table 88. Key Data Information from Secondary Sources

Table 89. Key Data Information from Primary Sources

Table 90. Authors List of This Report

List of Figures

Figure 1. Non-Invasive Cancer Detection Picture

Figure 2. Global Non-Invasive Cancer Detection Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Non-Invasive Cancer Detection Market Share by Type: 2025 vs 2032

Figure 4. Imaging Test Features

Figure 5. Nuclear Medicine Test Features

Figure 6. Others Features

Figure 7. Global Non-Invasive Cancer Detection Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Non-Invasive Cancer Detection Market Share by Application: 2025 vs 2032

Figure 9. Prostate Cancer Case Studies

Figure 10. Bladder Cancer Case Studies

Figure 11. Pancreatic Cancer Case Studies

Figure 12. Breast Cancer Case Studies

Figure 13. Gastric Cancer Case Studies

Figure 14. Others Case Studies

Figure 15. Non-Invasive Cancer Detection Report Years Considered

Figure 16. Global Non-Invasive Cancer Detection Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 17. Global Non-Invasive Cancer Detection Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 18. Global Non-Invasive Cancer Detection Market Share by Region: 2025 vs 2032

Figure 19. Global Non-Invasive Cancer Detection Market Share by Players in 2025

Figure 20. Global Non-Invasive Cancer Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 21. The Top 10 and 5 Players Market Share by Non-Invasive Cancer Detection Revenue in 2025

Figure 22. North America Non-Invasive Cancer Detection Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. North America Non-Invasive Cancer Detection Market Share by Country (2021–2032)

Figure 24. United States Non-Invasive Cancer Detection Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Canada Non-Invasive Cancer Detection Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Europe Non-Invasive Cancer Detection Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Europe Non-Invasive Cancer Detection Market Share by Country (2021–2032)

Figure 28. Germany Non-Invasive Cancer Detection Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. France Non-Invasive Cancer Detection Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. U.K. Non-Invasive Cancer Detection Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Italy Non-Invasive Cancer Detection Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Russia Non-Invasive Cancer Detection Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Ireland Non-Invasive Cancer Detection Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Asia-Pacific Non-Invasive Cancer Detection Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Asia-Pacific Non-Invasive Cancer Detection Market Share by Region (2021–2032)

Figure 36. China Non-Invasive Cancer Detection Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Japan Non-Invasive Cancer Detection Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. South Korea Non-Invasive Cancer Detection Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Southeast Asia Non-Invasive Cancer Detection Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. India Non-Invasive Cancer Detection Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Australia & New Zealand Non-Invasive Cancer Detection Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Latin America Non-Invasive Cancer Detection Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Latin America Non-Invasive Cancer Detection Market Share by Country (2021–2032)

Figure 44. Mexico Non-Invasive Cancer Detection Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Brazil Non-Invasive Cancer Detection Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Middle East & Africa Non-Invasive Cancer Detection Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Middle East & Africa Non-Invasive Cancer Detection Market Share by Country (2021–2032)

Figure 48. Israel Non-Invasive Cancer Detection Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Saudi Arabia Non-Invasive Cancer Detection Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. UAE Non-Invasive Cancer Detection Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Trublood Revenue Growth Rate in Non-Invasive Cancer Detection Business (2021–2026)

Figure 52. Datar Cancer Genetics Revenue Growth Rate in Non-Invasive Cancer Detection Business (2021–2026)

Figure 53. Nucleix Revenue Growth Rate in Non-Invasive Cancer Detection Business (2021–2026)

Figure 54. miR Scientific Revenue Growth Rate in Non-Invasive Cancer Detection Business (2021–2026)

Figure 55. Owlstone Medical Revenue Growth Rate in Non-Invasive Cancer Detection Business (2021–2026)

Figure 56. bioAffinity Technologies Revenue Growth Rate in Non-Invasive Cancer Detection Business (2021–2026)

Figure 57. Nonacus Revenue Growth Rate in Non-Invasive Cancer Detection Business (2021–2026)

Figure 58. Amadix Revenue Growth Rate in Non-Invasive Cancer Detection Business (2021–2026)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Noninvasive Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Liquid Biopsy For Cancer Diagnostics Market Research Report 2024

Global Noninvasive Cancer Biomarkers Market Research Report 2024

Global Canine Cancer Detection Market Research Report 2024

Non Invasive Cancer Diagnostics Market

Non Invasive Prenatal Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Canine Tumor Screening Market Research Report 2024

Global Canine Fluid Biopsy Market Research Report 2025

Global Canine Liquid Biopsy Market Research Report 2024

Global Liquid Tumor Biopsy Market Research Report 2024

Global Canine Biopsy Services Market Research Report 2025

Global Multi Cancer Detection Blood Test Market Research Report 2024

Global Non invasive Diagnosis Market Research Report 2025

Global Cell free Tumor DNA Detection Market Research Report 2025

Global Circulating Tumor DNA Diagnostics Market Research Report 2025

Global Cell Free DNA cfDNA Testing Market Research Report 2024

Global Mobile Cancer Screening Devices Market Insights Forecast to 2030

Global Non Invasive Prenatal DNA Testing Service Market Research Report 2024

Global Liquid Biopsy Products Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions